Published in Curr Top Microbiol Immunol on January 01, 2003
Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol (2010) 1.41
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
Viable offspring derived from fetal and adult mammalian cells. Nature (1997) 22.46
Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell (2001) 12.42
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med (2000) 11.35
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med (2001) 10.36
Chimerism of the transplanted heart. N Engl J Med (2002) 8.69
Functional arteries grown in vitro. Science (1999) 6.08
A completely biological tissue-engineered human blood vessel. FASEB J (1998) 5.82
Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science (2002) 5.64
Tissue engineering--current challenges and expanding opportunities. Science (2002) 5.03
Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol (2002) 4.82
Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science (2001) 4.69
The evolving concept of a stem cell: entity or function? Cell (2001) 4.26
Production of alpha 1,3-galactosyltransferase-deficient pigs. Science (2002) 3.96
Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med (2000) 3.94
Nuclear cloning and epigenetic reprogramming of the genome. Science (2001) 3.79
Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med (1998) 3.77
Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med (1998) 3.28
Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg (1981) 2.85
Myocyte renewal and ventricular remodelling. Nature (2002) 2.80
Myoblast transplantation for heart failure. Lancet (2001) 2.71
An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol (2001) 2.62
Stem cells in tissue engineering. Nature (2001) 2.62
Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 2.52
Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med (1995) 2.31
Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation (2000) 2.25
Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest (1996) 2.20
Xenografting: probability, possibility, or pipe dream? Lancet (1993) 2.08
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med (1997) 1.88
Inductive epitheliomesenchymal interaction in cultured organ rudiments of the mouse. Science (1953) 1.88
Formation of basement membranes in the embryonic kidney: an immunohistological study. J Cell Biol (1981) 1.88
The generation of transgenic pigs as potential organ donors for humans. Nat Med (1995) 1.86
Human and porcine early kidney precursors as a new source for transplantation. Nat Med (2002) 1.73
Nuclear reprogramming of human somatic cells by xenopus egg extract requires BRG1. Curr Biol (2004) 1.70
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science (2000) 1.64
The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States. JAMA (1992) 1.54
Invertebrate immune recognition, natural immunity and the evolution of positive selection. Immunol Today (1994) 1.53
Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology (2003) 1.48
Assessment with the dermal torque meter of skin pliability after treatment of burns with cultured skin substitutes. J Burn Care Rehabil (2000) 1.47
Xenotransplantation and the future of renal replacement. J Am Soc Nephrol (2004) 1.47
Faithful expression of imprinted genes in cloned mice. Science (2002) 1.45
Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg (1991) 1.44
In vivo modulation of the allogeneic immune response by human fetal kidneys: the role of cytokines, chemokines, and cytolytic effector molecules. Transplantation (2000) 1.43
Fibrin gel -- advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg (2001) 1.41
Transplantation of developing metanephroi into adult rats. Kidney Int (1998) 1.33
Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation (1997) 1.29
New directions for organ transplantation. Nature (1998) 1.27
Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg (1995) 1.24
Delayed xenograft rejection. Immunol Today (1996) 1.23
Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg (1999) 1.15
Hepatocellular transplantation in acute liver failure. Surgery (1977) 1.12
The immunological barrier to xenotransplantation. Immunity (2001) 1.10
Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival. Proc Natl Acad Sci U S A (1987) 1.10
The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation (2000) 1.09
Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg (2000) 1.08
Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation (2000) 1.07
A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation (2001) 1.01
The kidney in cardiovascular disease. Ann Intern Med (2001) 1.01
Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection. J Immunol (1995) 1.00
Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg (2000) 0.99
Transplantation of rat metanephroi into mice. Am J Physiol Regul Integr Comp Physiol (2001) 0.97
Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum Immunol (1997) 0.97
Xenotransplantation and other means of organ replacement. Nat Rev Immunol (2001) 0.94
Engraftment of human kidney tissue in rat radiation chimera: II. Human fetal kidneys display reduced immunogenicity to adoptively transferred human peripheral blood mononuclear cells and exhibit rapid growth and development. Transplantation (1997) 0.93
Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg (2000) 0.93
Transfer of bilirubin uridine diphosphate-glucuronyltransferase to enzyme-deficient rats. Science (1970) 0.88
In vivo osteogenic durability of cultured bone in porous ceramics: a novel method for autogenous bone graft substitution. Transplantation (2000) 0.87
Transplantation of embryonic organs - kidney and pancreas. Am J Transplant (2004) 0.86
Connective tissue response to tubular implants for peripheral nerve regeneration: the role of myofibroblasts. J Comp Neurol (2000) 0.84
Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs. Transplant Proc (1995) 0.83
Xenotransplantation--state of the art--update 1999. Front Biosci (1999) 0.83
Mechanisms of thrombotic microangiopathy following xenogeneic hematopoietic progenitor cell transplantation. Transplantation (2001) 0.83
Fusion of approaches to the treatment of organ failure. Am J Transplant (2004) 0.83
Transplantation of hepatocytes in nonhuman primates: a preclinical model for the treatment of hepatic metabolic diseases. Transplantation (2001) 0.82
The role of vascular smooth muscle cell integrins in the compaction and mechanical strengthening of a tissue-engineered blood vessel. Tissue Eng (1999) 0.80
Knocking out xenograft rejection. Nat Biotechnol (2002) 0.80
Prolonged survival of discordant porcine islet xenografts. Transplantation (1996) 0.79
Evaluation of methods of hepatotrophic stimulation in rat heterotopic hepatocyte transplantation using polymers. J Pediatr Surg (1999) 0.79
A new technology in burn therapy: INTEGRA artificial skin. Dimens Crit Care Nurs (2000) 0.78
Small intestinal submucosa as a small-caliber venous graft: a novel model for hepatocyte transplantation on synthetic biodegradable polymer scaffolds with direct access to the portal venous system. J Pediatr Surg (1999) 0.78
Matrices for tissue engineering-scaffold structure for a bioartificial liver support system. J Control Release (2000) 0.78
Interspecies chimeras: an experimental approach for studies on embryonic angiogenesis. Med Biol (1985) 0.77
The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants. J Thorac Cardiovasc Surg (2000) 0.76
Glycans derived from porcine stomach mucin are effective inhibitors of natural anti-alpha-galactosyl antibodies in vitro and after intravenous infusion in baboons. Transplantation (1996) 0.76
Long-term insulin-secretory function of islets of Langerhans encapsulated with a layer of confluent chondrocytes for immunoisolation. Pediatr Surg Int (1999) 0.75
Genetic therapies and xenotransplantation. Expert Opin Biol Ther (2002) 0.75